<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
	<headerData>
        <submissionType>144</submissionType>
                <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001793412</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
        <liveTestFlag>LIVE</liveTestFlag>




                </filerInfo>
    </headerData>

     <formData>
        <issuerInfo>
            <issuerCik>0001806310</issuerCik>
			<issuerName>TAYSHA GENE THERAPIES, INC.</issuerName>


			    <secFileNumber>001-39536</secFileNumber>


			<issuerAddress>
				<com:street1>3000 PEGASUS PARK DRIVE</com:street1>
                				<com:street2>SUITE 1430</com:street2>
                				<com:city>DALLAS</com:city>
				<com:stateOrCountry>TX</com:stateOrCountry>
				<com:zipCode>75247</com:zipCode>
			</issuerAddress>

			<issuerContactPhone>214-612-0000</issuerContactPhone>
			<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kamran Alam</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>

			<relationshipsToIssuer>

				    <relationshipToIssuer>Officer</relationshipToIssuer>

			</relationshipsToIssuer>
		</issuerInfo>

				          <securitiesInformation>
			<securitiesClassTitle>Common Stock</securitiesClassTitle>
			<brokerOrMarketmakerDetails>
				<name>Maxim Group LLC</name>
				<address>
				<com:street1>300 Park Avenue, 16th Floor</com:street1>
                				<com:city>New York</com:city>
				<com:stateOrCountry>NY</com:stateOrCountry>
				<com:zipCode>10022</com:zipCode>
				</address>
			</brokerOrMarketmakerDetails>
			<noOfUnitsSold>54491</noOfUnitsSold>
			<aggregateMarketValue>156389.17</aggregateMarketValue>
			<noOfUnitsOutstanding>272794885</noOfUnitsOutstanding>
			<approxSaleDate>08/21/2025</approxSaleDate>
			<securitiesExchangeName>Nasdaq</securitiesExchangeName>
		</securitiesInformation>

    		       <securitiesToBeSold>
         <securitiesClassTitle>Common Stock</securitiesClassTitle>
         <acquiredDate>08/21/2025</acquiredDate>
         <natureOfAcquisitionTransaction>RSU Award</natureOfAcquisitionTransaction>
                  <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
                  <isGiftTransaction>N</isGiftTransaction>
		          <amountOfSecuritiesAcquired> 54491</amountOfSecuritiesAcquired>
                  <paymentDate>08/21/2025</paymentDate>
                  <natureOfPayment>Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.</natureOfPayment>
      </securitiesToBeSold>

    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>


    		<remarks>The Reporting Person is selling the securities set forth herein pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.</remarks>

        <noticeSignature>
            <noticeDate>08/21/2025</noticeDate>
                        <signature> /s/ Kamran Alam</signature>
        </noticeSignature>
	</formData>
    </edgarSubmission>
